LEP and metabolic dysfunction-associated steatohepatitis: Patel et al. reported that WFA prevented and improved liver injury in nonalcoholic steatohepatitis [27], even in high-fat-diet-treated leptin-deficient ob/ob mice, indicating that the hepatoprotective effect of WFA was in a leptin-independent manner in nonalcoholic steatohepatitis.